BioXcel Therapeutics Appoints Vincent J. O’Neill M.D., as Senior Vice President and Chief Medical Officer Jun 7, 2018
BioXcel Therapeutics and Nektar Therapeutics Present Preclinical Pancreatic Cancer Data for BXCL701, NKTR-214 and Anti-PD1 Combination Therapy at ASCO 2018 Annual Meeting Jun 4, 2018
BioXcel Therapeutics Reports First Quarter 2018 Financial Results and Provides Business Update May 14, 2018
